# ADDF's Diagnostics Accelerator

> ADDF's Diagnostics Accelerator is a VC fund in New York backing Biotechnology and Health Care. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: New York, United States
- Total investments: 4
- Last investment: Dec 2023
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/alzheimer's-drug-discovery-foundation
- Website: https://www.alzdiscovery.org/research-and-grants/diagnostics-accelerator

ADDF's Diagnostics Accelerator is a VC fund in New York focused on Biotechnology and Health Care. ADDF's Diagnostics Accelerator challenges the research community to develop cutting-edge biomarkers and explore novel diagnostic technologies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 3 | 75% |
| Health Care | 2 | 50% |
| Pharmaceutical | 2 | 50% |
| Life Science | 1 | 25% |
| Medical Device | 1 | 25% |

6 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 1 | 25% |
| Series A | 1 | 25% |
| Funding Round | 1 | 25% |
| Venture - Series Unknown | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Spain | 1 | 25% |
| Canada | 1 | 25% |
| United States | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Superfluid Dx | Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy versus disease state. |  | Series A | Dec 20, 2023 |  |
| ADmit Therapeutics | ADmit Therapeutics is a biotechnology company that specializes in the development of early Alzheimer's disease diagnosis tests. The company's test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA by next-generation sequencing, enabling medical practitioners with aneasy way to detect early-stage Alzheimer. | $6.1M | Venture - Series Unknown | Jul 19, 2023 |  |
| Superfluid Dx | Tissue-specific cell-free circulating RNA is a newly developed area for molecular diagnosis. Based on this powerful non-invasive approach, Molecular Stethoscope aims to transform healthcare by providing early insight into a patient’s healthy versus disease state. |  | Grant | Jun 07, 2022 |  |
| Optina Diagnostics | Optina Diagnostics develops technology for the early detection of disease through the eye. | $2.1M |  | Jan 24, 2022 |  |

4 of 4 investments shown.

## Co-investors
- [Alzheimer's Drug Discovery Foundation](https://shizune.co/investors/profile/alzheimers-drug-discovery-foundation) — VC Fund, 3 deals together
- [Ship2B](https://shizune.co/investors/profile/b-come-ship2b) — VC Fund, 1 deal together
- [Clave Capital](https://shizune.co/investors/profile/clave-capital) — VC Fund, 1 deal together
- [European Innovation Council](https://shizune.co/investors/profile/european-innovation-council) — VC Fund, 1 deal together
- [Lavanda Ventures](https://shizune.co/investors/profile/lavanda-ventures) — VC Fund, 1 deal together
- [Premji Invest](https://shizune.co/investors/profile/premjiinvest) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does ADDF's Diagnostics Accelerator invest in?

ADDF's Diagnostics Accelerator invests primarily in Biotechnology, Health Care and Pharmaceutical startups, most often at Grant and Series A stage. Most of the 4 investments tracked by Shizune back companies in Spain. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did ADDF's Diagnostics Accelerator last invest?

The most recent investment recorded for ADDF's Diagnostics Accelerator closed in Dec 2023. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co